R&D at other companies
Other financials
Where this comes from
Reported directly by Sanara MedTech Inc. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sanara MedTech Inc.'s r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Sanara MedTech Inc.'s R&D?
- Sanara MedTech Inc. (SMTI) reported R&D of $759.59K in Q1 2026.
- How has Sanara MedTech Inc.'s R&D changed year-over-year?
- Sanara MedTech Inc.'s R&D decreased by 20.1% year-over-year, from $950.36K to $759.59K.
- What is the long-term trend for Sanara MedTech Inc.'s R&D?
- Over 4 years (2021 to 2025), Sanara MedTech Inc.'s R&D has grown at a 75.3% compound annual growth rate (CAGR), from $558.7K to $5.27M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.